RAPT Therapeutics (RAPT) Stock Highlights

1.82 | -4.21%

2024-09-19 06:21:58

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

Statistics

Range Today

1.82 1.96

Volume Today 161.2K

Range 1 Year

1.77 27.35

Volume 1 Year 173.18M

Range 3 Year

1.77 40.74

Volume 3 Year 341.72M

Range 10 Year

1.77 51.21

Volume 10 Year 483.65M

Highlights

Market Capitalization 68.06M (small)

Floating Shares 31.55M

Current Price 1.82

Price To Earnings -0.62

Price To Book 0.62

Earnings Per Share -3.13

Payout Ratio 0%

Performance

Latest -4.21%

1 Month -17.27%

3 Months -44.85%

6 Months -78.64%

1 Year -90.69%

3 Years -95.27%

5 Years -85.14%

10 Years -85.14%

Benchmarks

Market Capitalization

197 / 368

Gross Profits

120 / 278

Total Revenue

299 / 300

Total Rank

351 / 368

Free Cashflow

217 / 352

Performance 5 years

264 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.